Edmund I Graziani

Years Active: 2017-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Edmund I Graziani, Matthew Sung, Dangshe Ma, Bitha Narayanan, Kimberly Marquette, Sujiet Puthenveetil, L Nathan Tumey, Jack Bikker, Jeffrey Casavant, Eric M Bennett, Manoj B Charati, Jonathon Golas, Christine Hosselet, Cynthia M Rohde, George Hu, Magali Guffroy, Hadi Falahatpisheh, Martin Finkelstein, Tracey Clark, Frank Barletta, Lioudmila Tchistiakova, Judy Lucas, Edward Rosfjord, Frank Loganzo, Christopher J O'Donnell, Hans-Peter Gerber, Puja Sapra
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers. Molecular cancer therapeutics 19 (10) (2020)
Anokha S Ratnayake, Li-Ping Chang, L Nathan Tumey, Frank Loganzo, Joseph A Chemler, Melissa Wagenaar, Sylvia Musto, Fengping Li, Jeffrey E Janso, T Eric Ballard, Brian Rago, Greg L Steele, WeiDong Ding, Xidong Feng, Christine Hosselet, Vlad Buklan, Judy Lucas, Frank E Koehn, Christopher J O'Donnell, Edmund I Graziani
Natural Product Bis-Intercalator Depsipeptides as a New Class of Payloads for Antibody-Drug Conjugates. Bioconjugate chemistry 30 (1) (2018)
Chethana Kulkarni, James E Finley, Andrew J Bessire, Xiaotian Zhong, Sylvia Musto, Edmund I Graziani
Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies. Bioconjugate chemistry 28 (4) (2017)

Edmund I Graziani.css-eqlu8i{font-size:small;padding-left:4px;}